Your browser doesn't support javascript.
loading
Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial.
Putananickal, Niveditha; Gross, Elena C; Orsini, Anna-Lena; Schmidt, Simone; Hafner, Patricia; Gocheva, Vanya; Nagy, Sara; Henzi, Bettina C; Rubino, Daniela; Vogt, Deborah R; Cichon, Sven; Sandor, Peter; Fischer, Dirk.
Affiliation
  • Putananickal N; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Gross EC; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Orsini AL; Department of Neurology, University of Basel Hospital, University of Basel, Switzerland.
  • Schmidt S; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Hafner P; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Gocheva V; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Nagy S; Department of Neurology, University of Basel Hospital, University of Basel, Switzerland.
  • Henzi BC; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Rubino D; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Vogt DR; Department of Clinical research, Clinical Trial Unit, University of Basel Hospital, University of Basel, Switzerland.
  • Cichon S; Institute of Medical Genetics and Pathology, University of Basel Hospital, University of Basel, Switzerland.
  • Sandor P; Department of Biomedicine, University of Basel, Switzerland.
  • Fischer D; RehaClinic, Bad Zurzach, Switzerland.
Cephalalgia ; 42(4-5): 302-311, 2022 04.
Article in En | MEDLINE | ID: mdl-34541914

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Migraine Disorders Type of study: Clinical_trials Limits: Humans Language: En Journal: Cephalalgia Year: 2022 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Migraine Disorders Type of study: Clinical_trials Limits: Humans Language: En Journal: Cephalalgia Year: 2022 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom